Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - In vitro and In vivo Oncology

Inducing anti-tumor immunity in melanoma by delivery of mRNA loaded on a new positive charge hyper-branch cyclodextrin polymer; a novel theranostic approach.

Yousef Khazaei Monfared, Mohammad Mahmoudian, Claudio cecone, Shadi Esfahani, Tomoya Hayashi, Ken Ishii, Parvin Mialni-Zakeri, adrian Matenco and Francesco Trotta
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P28;
Yousef Khazaei Monfared
1Dip. Di Chimica, Università di Torino, via P. Giuria 7, 10125, Torino, Italy. 2.Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Mahmoudian
2Tabriz university of medical science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio cecone
3Turin university
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shadi Esfahani
4Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoya Hayashi
5Tokyo University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Ishii
5Tokyo University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parvin Mialni-Zakeri
2Tabriz university of medical science
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
adrian Matenco
3Turin university
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Trotta
3Turin university
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inducing anti-tumor immunity in melanoma by delivery of mRNA loaded on a new positive charge hyper-branch cyclodextrin polymer; a novel theranostic approach.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Inducing anti-tumor immunity in melanoma by delivery of mRNA loaded on a new positive charge hyper-branch cyclodextrin polymer; a novel theranostic approach.
Yousef Khazaei Monfared, Mohammad Mahmoudian, Claudio cecone, Shadi Esfahani, Tomoya Hayashi, Ken Ishii, Parvin Mialni-Zakeri, adrian Matenco, Francesco Trotta
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P28;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Inducing anti-tumor immunity in melanoma by delivery of mRNA loaded on a new positive charge hyper-branch cyclodextrin polymer; a novel theranostic approach.
Yousef Khazaei Monfared, Mohammad Mahmoudian, Claudio cecone, Shadi Esfahani, Tomoya Hayashi, Ken Ishii, Parvin Mialni-Zakeri, adrian Matenco, Francesco Trotta
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P28;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluating ΔFFNP-PET as an imaging biomarker of estrogen receptor α (ERα) functional status in preclinical models of ERα+ breast cancer with ESR1 mutations
  • PET Imaging Study of 68Ga-Labeled GZP Probe for Diagnosis and Therapeutic Monitoring of Acute-Graft-Versus-Host Disease (aGVHD) in Mice
  • Highly potent [225Ac]Ac-macropa-trastuzumab-PEG6-DM1 antibody drug radioconjugate against HER2-positive breast cancer xenografts
Show more Oncology, Basic and Translational - In vitro and In vivo Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire